Riboulet-Zemouli Kenzi, Allué Creus Josep
European Union Traditional Cannabis Medicines (EUTC) Research, 08001 Barcelona, Spain.
Sociedad Clínica de Endocannabinología (SCE), 08015 Barcelona, Spain.
Pharmaceuticals (Basel). 2024 Nov 25;17(12):1585. doi: 10.3390/ph17121585.
This study explores the trajectory of interest in and use of (hemp extract, i.e., extract of L.) for the symptomatic treatment of minor gastrointestinal distress and dyspepsia in nineteenth- and early twentieth-century Barcelona (Catalonia, Spain) prior to 1939, through a review of primary sources. The objective of this paper is to present a historical pharmaceutical and applied review of the medical use of the hemp genus ( L.) prior to its prohibition, thereby contributing to its recognition as a medicinal product. The information provided demonstrates evidence of the medicinal use of cannabis within the historical context studied. The interactions between this legacy medical use and the contemporary body of pharmacological and toxicological knowledge (on hemp, its constituents, and the endocannabinoid system in gastrointestinal and stomach disorders) are discussed, providing new possible clinical perspectives. Within its limitations-including the scope, limited accessibility to, and varying quality of archives-this research contributes to a more granular understanding of the historical embeddedness of psychoactive hemp medicines in northeastern Spain, suggesting that medical and pharmaceutical traditions could play a role in informing contemporary approaches to "medical marijuana".
本研究通过对一手资料的回顾,探究了1939年之前19世纪和20世纪初西班牙加泰罗尼亚巴塞罗那地区,用于对症治疗轻微胃肠道不适和消化不良的大麻提取物(即大麻提取物)的兴趣轨迹和使用情况。本文的目的是在大麻被禁止之前,对大麻属植物的医学用途进行历史药学和应用综述,从而有助于将其认可为一种药品。所提供的信息证明了在研究的历史背景下大麻的药用证据。本文讨论了这种传统医学用途与当代药理学和毒理学知识体系(关于大麻、其成分以及胃肠道和胃部疾病中的内源性大麻素系统)之间的相互作用,提供了新的可能的临床观点。尽管存在局限性,包括研究范围、档案获取有限以及质量参差不齐等,但这项研究有助于更细致地理解西班牙东北部精神活性大麻药物的历史根源,表明医学和药学传统可能有助于为当代“医用大麻”方法提供信息。